These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25363467)

  • 1. Online reporting of pseudoephedrine pharmacy sales: does Australia require a mandatory system?
    Devaney M; Ferris J; Mazerolle L
    Int J Pharm Pract; 2015 Aug; 23(4):248-255. PubMed ID: 25363467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pseudoephedrine pharmacy sales before and after mandatory recording requirements in Western Australia: a case study.
    Hattingh HL; Varsani J; Kachouei LA; Parsons R
    Subst Abuse Treat Prev Policy; 2016 Aug; 11(1):30. PubMed ID: 27577258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linked electronic medication systems in community pharmacies for preventing pseudoephedrine diversion: a review of international practice and analysis of results in Australia.
    Berbatis CG; Sunderland VB; Dhaliwal SS
    Drug Alcohol Rev; 2009 Nov; 28(6):586-91. PubMed ID: 19930010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
    Emmerton L
    J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical sales of pseudoephedrine: the impact of electronic tracking systems on methamphetamine crime incidents.
    Mazerolle L; McGuffog I; Ferris J; Chamlin MB
    Addiction; 2017 Mar; 112(3):468-474. PubMed ID: 27741563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pseudoephedrine regulation at Australian pharmacies through Project Stop: A narrative review.
    Brookfield S; Gartner C
    Drug Alcohol Rev; 2024 Jan; 43(1):325-342. PubMed ID: 37963493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing community pharmacist engagement in a policing partnership strategy to reduce the illicit diversion of pseudoephedrine products.
    Webster JL
    Res Social Adm Pharm; 2013; 9(6):903-17. PubMed ID: 23548589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural aspects surrounding medicine purchases from pharmacies in Australia.
    Emmerton L
    Pharm Pract (Granada); 2008 Jul; 6(3):158-64. PubMed ID: 25177407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-prescription medicines: current issues in Australian community pharmacy.
    Tan AC; Emmerton L
    Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the coding of complications in Queensland and Victorian admitted patient data.
    Michel JL; Cheng D; Jackson TJ
    Aust Health Rev; 2011 Aug; 35(3):245-52. PubMed ID: 21871182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of facsimile cards for pharmacy-access products containing pseudoephedrine or ephedrine.
    Chanda S; Sansgiry SS
    J Am Pharm Assoc (2003); 2008; 48(1):52-7. PubMed ID: 18192131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the risk of a scuba diving fatality in Australia.
    Lippmann J; Stevenson C; McD Taylor D; Williams J
    Diving Hyperb Med; 2016 Dec; 46(4):241-246. PubMed ID: 27966203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notification of patients with acute flaccid paralysis since certification of Australia as polio-free.
    Whitfield K; Kelly H
    J Paediatr Child Health; 2004 Aug; 40(8):466-9. PubMed ID: 15265189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of over-the-counter insomnia complaints in Australian community pharmacies: a standardized patient study.
    Kashyap KC; Nissen LM; Smith SS; Kyle G
    Int J Pharm Pract; 2014 Apr; 22(2):125-34. PubMed ID: 23947610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the medication pathway in rural Queensland, Australia.
    Tan AC; Emmerton L; Hattingh HL
    Int J Pharm Pract; 2012 Oct; 20(5):324-39. PubMed ID: 22953772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing and medication-initiation roles based on the perspectives of rural healthcare providers in a study community in Queensland.
    Tan AC; Emmerton LM; Hattingh HL
    Aust Health Rev; 2013 May; 37(2):172-7. PubMed ID: 23575505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unintentional mortality associated with paracetamol and codeine preparations, with and without doxylamine, in Australia.
    Hopkins RE; Dobbin M; Pilgrim JL
    Forensic Sci Int; 2018 Jan; 282():122-126. PubMed ID: 29182956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-prescription medicines: a process for standards development and testing in community pharmacy.
    Benrimoj SC; Gilbert A; Quintrell N; Neto AC
    Pharm World Sci; 2007 Aug; 29(4):386-94. PubMed ID: 17333499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.